1IJK image
Deposition Date 2001-04-26
Release Date 2002-07-10
Last Version Date 2024-11-06
Entry Detail
PDB ID:
1IJK
Title:
The von Willebrand Factor mutant (I546V) A1 domain-botrocetin Complex
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Bothrops jararaca (Taxon ID: 8724)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.27
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:von Willebrand factor
Gene (Uniprot):VWF
Mutagens:I546V
Chain IDs:A
Chain Length:202
Number of Molecules:1
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Botrocetin
Chain IDs:B
Chain Length:133
Number of Molecules:1
Biological Source:Bothrops jararaca
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Botrocetin
Chain IDs:C
Chain Length:125
Number of Molecules:1
Biological Source:Bothrops jararaca
Primary Citation
Structural basis of von Willebrand factor activation by the snake toxin botrocetin.
Structure 10 943 950 (2002)
PMID: 12121649 DOI: 10.1016/S0969-2126(02)00787-6

Abstact

The A1 domain of von Willebrand factor (vWF) mediates platelet adhesion to sites of vascular injury by binding to the platelet receptor glycoprotein Ib (GpIb), an interaction that is regulated by hydrodynamic shear forces. The GpIb binding surface of A1 is distinct from a regulatory region, suggesting that ligand binding is controlled allosterically. Here we report the crystal structures of the "gain-of-function" mutant A1 domain (I546V) and its complex with the exogenous activator botrocetin. We show that botrocetin switches the mutant A1 back toward the wild-type conformation, suggesting that affinity is enhanced by augmenting the GpIb binding surface rather than through allosteric control. Functional studies of platelet adhesion under flow further suggest that the activation mechanism is distinct from that of the gain-of-function mutation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures